Find out why Vertex Pharmaceuticals is on the list. Skip to Content. Explore Close. Subscribe. back to list. TIME100 Most Influential Companies 2025. Filter. Jun 26, 2025 4:24 AM PT.

BOSTON & OSAKA, Japan, June 23, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Ono Pharmaceutical Co., Ltd. (OTCMKTS: OPHLY) today announced an exclusive collaboration and license ...

The need-to-know this morning. Novo Nordisk terminated its marketing relationship with Hims & Hers, accusing the telehealth company of deceptive marketing practices and selling “illegitimate ...

Vertex Pharmaceuticals Incorporated (VRTX) Benefited from the Launch of its New Drug. Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first ...

After a strong run, the shares of Vertex, Inc. (NASDAQ:VERX) tumbled -34%. This end-to-end tax compliance software solutions provider reported fourth quarter results that were mostly in line with ...

A high-level overview of Vertex Pharmaceuticals Incorporated (VRTX) stock. View (VRTX) real-time stock price, chart, news, analysis, analyst reviews and more.

Vertex could be closing in on a deal with the NHS over its portfolio of cystic fibrosis drugs, after health ministers wrote to the US firm asking for a conclusion to talks after almost two years ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880.

A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...

Access Vertex stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.

Read about Vertex Pharmaceuticals Inc (VRTX:XNAS) stock and today's latest news and financial updates.